Cost-effectiveness of dienogest compared to gonadotropin releasing hormone agonists for the management of endometriosis in Vietnam.

ABSTRACT:

Objectives

Endometriosis-related dysmenorrhea and pelvic pain impose significant economic and quality-of-life burdens. This study evaluated the cost-effectiveness of dienogest compared to gonadotropin-releasing hormone agonists (GnRH-a) for managing dysmenorrhea and pelvic pain in Vietnam.

Design

The cost-effectiveness analysis using a Markov model was conducted from a healthcare payer perspective. Model input parameters were obtained from meta-analyses, published literature, and local data sources. One-way sensitivity, and probabilistic sensitivity analyses (PSA) were performed to assess the robustness of the findings.

Setting

Vietnamese healthcare system context.

Participants

Hypothetical cohort of women with endometriosis experiencing dysmenorrhea or pelvic

SUBMITTER: Kieu MTT 

PROVIDER: S-EPMC12482696 | biostudies-literature | 2025 Sep

REPOSITORIES: biostudies-literature